MERGE Continues Growth Trajectory with Strategic Additions to Leadership
CHICAGO, June 11, 2025--(BUSINESS WIRE)--MERGE, a leading marketing and technology agency, announces two strategic hires to strengthen and further accelerate its mission of integrated growth and innovation. Heidi West steps into the role of Chief Revenue Officer, and John Bracey joins MERGE as Chief Data and Performance Officer. These accomplished executives bring decades of experience and expertise, fortifying the agency's leadership team as it continues to expand at the intersection of health and wellness.
Heidi West, MERGE's new Chief Revenue Officer, offers over 30 years of exceptional sales leadership and a history of delivering impactful technology solutions across healthcare, including at CommonSpirit Health, Englewood Health, Mount Sinai Health System, Stanford Health Care, and other diverse industries. Most recently leading the healthcare team at Zoom, West has held sales and leadership roles at Cisco, Nutanix, and Booz Allen.
"I am incredibly excited to join MERGE at such a pivotal time," said West. "I look forward to leveraging my experience in healthcare and technology to help MERGE bridge the gap between health and consumer verticals. By focusing on improving patient engagement and experience, we can deliver trusted, relatable solutions guided by AI and data-driven strategies for our clients and their audiences."
West's background in healthcare and executive engagement, combined with her talent for building high-performing sales teams aligned with strategic goals, makes her an invaluable catalyst for strategic growth. Commenting on this significant leadership addition, Stephanie Trunzo, MERGE CEO, remarked, "While leading Oracle Health, I met Heidi in her role driving the health business at Zoom. Her extensive experience in the health industry, coupled with her strategic sales expertise and sincere approach will catalyze the outcome-oriented momentum of our client service and business development teams." Beyond her professional achievements, West is a passionate advocate for women in technology and STE(A)M initiatives.
John Bracey, a visionary in data science and analytics, brings an impressive track record of transforming global brands into organizations driven by insight. Formerly EVP at Publicis Groupe, Bracey spearheaded data-driven transformation initiatives across a number of Publicis Groupe's largest consumer and healthcare brands.
"My expertise lies where data science and strategy meet. I'm passionate about helping brands maximize the value of their data and media investments, whether by engineering insight or architecting performance," said Bracey. "Across industries, I've seen that an audience-first approach consistently drives better insights and stronger outcomes. At MERGE, I look forward to continuing this work, turning complex data into automated, actionable solutions that deliver measurable business outcomes."
"John's ability to harness data to transform businesses will substantively enhance how we deliver personalized, meaningful solutions that unite people and brands. These data-smart offerings will be the electricity that runs through creative and tech implementations to identify, optimize, and predictively model impact. We're incredibly excited about the amplified innovation he will bring to MERGE," said Trunzo.
The West and Bracey appointments further accelerate MERGE's strategic leadership expansion, building on the other significant executive announcements this year beginning with Stephanie Trunzo's announcement as CEO, and including Erica Denner (Chief People Officer), Kyle Smith (CTO), Paul Buranosky (CMO), and Chris Esposito (CFO).
About MERGE
MERGE is a marketing and technology agency built for the intersection of health and wellness. We combine deep expertise in health and consumer behavior with strategy, creativity, experience technology, and digital marketing to design personalized experiences that drive meaningful results.
Powered by human insight, creativity, and AI, we weave storytelling through technology to turn complexity into clarity — strengthening relationships between people and brands.
With 750+ specialists across Atlanta, Boston, Chicago, Denver, Kansas City, Los Angeles, New York, and Raleigh, MERGE partners with leading brands like Abbott, GE Healthcare, American Express, T-Mobile, Coach, and Meta to advance health, wellness, and happiness.
Learn more at mergeworld.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250611413645/en/
Contacts
Mary Josephmjoseph@mergeworld.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
AppLovin (NasdaqGS:APP) Reports Robust Q1 Earnings Despite Price Dip Over Last Quarter
AppLovin reported robust Q1 earnings with sales growth and improved net income, yet it faced a 4% share price decline over the last quarter. The price move contrasts with the broader market's flat performance but can be partly attributed to the substantial goodwill impairment and the securities class action lawsuit filed against the company. Despite these challenges, the ongoing share repurchase program and strategic advancements like Chartboost's new capabilities on the MAX platform may have cushioned the impact. Meanwhile, impending board changes and M&A discussions could introduce new dynamics for the company's future trajectory. AppLovin has 3 warning signs we think you should know about. Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. The recent developments surrounding AppLovin, including the goodwill impairment and class action lawsuit, may introduce uncertainties that weigh on investor sentiment. While these challenges could pressure the company's revenue and earnings forecasts in the short term, the ongoing share repurchase program and strategic investments in AI and global advertising might support long-term growth trajectories. Over a three-year period, AppLovin's total shareholder return was very large, showcasing its resilience and potential for significant value creation. Despite a recent 4% share price decline, the company's one-year performance exceeded the US Software industry's 16.8% return, indicating robust comparative growth. With a current share price of US$304.62 and analysts' price target of US$432.90, the stock remains at a substantial discount, suggesting potential for future appreciation if the company meets earnings projections. Gain insights into AppLovin's historical outcomes by reviewing our past performance report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:APP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
an hour ago
- Yahoo
See how much an investor needs in an ISA to fund an £888 monthly passive income
Passive income has always struck me as the holy grail of investing. A regular payment landing in my account, without me having to lift a finger. Ideally, generated inside a Stocks and Shares ISA. To generate £888 a month, or £10,656 a year, I'd need to think carefully about what kind of payout I'm aiming for. Many people use the so-called 4% rule, which assumes investors draws 4% a year from a pot without running it down too fast. That would mean needing a hefty £266,400 to hit my income target. That's quite a chunk of change. But I think it's possible to bring that number down a fair bit, depending on the stocks I pick and the yields they offer. One of my favourite second income stocks is FTSE 100 wealth manager M&G (LSE: MNG). A year ago, it was yielding close to 10%. That's since dipped to around 7.9% as the shares have enjoyed a strong run. They've climbed 25% over 12 months, and 60% over five years. Not bad for a stock many wrote off as purely an income play. Possibly including me. M&G isn't without risk. Markets remain shaky, and the long shift to passive investing is still a threat to its active management model. With interest rates staying higher for longer, income seekers may find cash and bonds more tempting than equity income stocks, where capital is at risk. The dividend is set for modest growth, with the board targeting 2% annual increases. But there's still potential. On 30 May, M&G revealed that Japan's Dai-ichi Life will be taking a 15% stake, bringing an estimated $6bn of new investment into its funds over the next five years. That has given sentiment a lift. I suspect share price growth may slow after its strong run, but I think M&G is still worth considering with a long-term view. Even so, I wouldn't pile everything into a single income stock, no matter how juicy the yield. Instead, I'd spread my money around and aim for a more realistic average yield of 5.5%. With a 5.5% yield, I'd need around £193,745 in my ISA to generate £10,656 of annual income and hit that £888 monthly goal. That assumes I live off the dividends, and leave the capital untouched to keep growing over time. That's almost £195,000 which sounds like a lot, and it is. But over a 40-year working life, I think it's achievable. For example, investing just £75 a month at an average growth rate of 7% – roughly in line with the long-term FTSE 100 average – could do the trick. Naturally, there are risks. Stock markets can go down as well as up. Inflation will nibble away at the buying power of that £888. So I'd encourage anyone with long-term ambitions to save more if they can. But this shows that with patience, consistency and a little know-how, building a decent ISA income pot is far from impossible. I'd say income investors might consider buying high-yield stocks where the fundamentals still stack up, while diversifying to help smooth out the ride. The post See how much an investor needs in an ISA to fund an £888 monthly passive income appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Harvey Jones has positions in M&g Plc. The Motley Fool UK has recommended M&g Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Associated Press
2 hours ago
- Associated Press
Regalis Capital Harnesses AI to Improve M&A Outcomes
06/22/2025, Ontario // KISS PR Brand Story PressWire // In a high-stakes market where timing and accuracy dictate success, Regalis Capital is redefining the business acquisition landscape. Its game-changing approach is driven by predictive AI and a white-glove service model that makes it possible for U.S. buyers to seize cash-flowing businesses with unmatched speed, accuracy, and personalized support. This innovation marks a transformative shift in how entrepreneurs approach business ownership, replacing outdated M&A methods with a faster and more precise AI-supported strategy. While many firms provide advisory services, Regalis Capital takes the process several steps further. Its three-phase M&A strategy—Preparation, Execution, and Optimization—equips buyers with a powerful system built on real-world insights, deal data, and operational discipline. By combining predictive technology with hands-on support, Regalis Capital simplifies acquisitions without sacrificing strategic depth. 'Buying a business shouldn't feel overwhelming. It should feel empowering,' said a company representative . 'That's why our process is built to give buyers the clarity, support, and confidence they need to move forward.' Regalis Capital's competitive edge comes from its proprietary AI-backed deal flow system. It scans thousands of opportunities to match U.S. buyers with businesses that meet strict criteria—from profitability to industry fit. Once a target is identified, the firm supports negotiations, lending discussions, deal preparation and ensures a seamless close. This all-in-one approach is a radical departure from conventional advisory services, which often leave clients to manage critical steps themselves. It raises the bar for new and seasoned business buyers. Regalis Capital helps U.S. buyers acquire cash-flowing businesses across industries with minimal friction. Through tailored deal assessments, operational insights, and access to vetted lenders, it removes the usual M&A roadblocks. 'We do as much of the heavy lifting as humanly possible,' the representative added. 'That's not just a promise—it's how we operate.' This hands-on model positions Regalis Capital as a reliable guide in the complex world of business acquisition. Unlike generalist firms or high-volume platforms, it curates each opportunity with precision and strategy, providing a personalized experience that leaves buyers informed, equipped, and ready to lead. Founded to bring clarity and control to the acquisition process for U.S. buyers, the Ontario-based firm continues to lead with strategy and innovation. Using predictive tools and expert guidance, it streamlines business ownership transitions. As the only M&A advisory offering a fully done-for-you acquisition model powered by AI, Regalis Capital is more than a partner—it offers a competitive advantage. With a proven process and predictive strategy, Regalis Capital is changing how entrepreneurship through acquisition gets done. For U.S. buyers seeking clarity, speed, and success in M&A, the firm delivers not just support but also outcomes. To learn more about Regalis Capital, visit About Regalis Capital Regalis Capital is a boutique M&A advisory firm based in Niagara-on-the-Lake, Ontario, Canada, specializing in helping U.S. citizens acquire cash-flowing businesses through a fully done-for-you process. As the only white-glove firm of its kind, Regalis Capital combines proprietary AI technology with deep industry expertise to deliver deals that are vetted, funded, negotiated, and closed with precision. With a mission to remove complexity from business acquisition, the firm empowers everyday entrepreneurs to own high-performing companies with confidence and clarity. ### Media Contact Regalis Capital Address: Ontario, Canada Phone: (647) 946-8687 Website: Source published by Submit Press Release >> Regalis Capital Harnesses AI to Improve M&A Outcomes
